Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cells.

Brinkmann K, Ng AP, de Graaf CA, Di Rago L, Hyland CD, Morelli E, Rautela J, Huntington ND, Strasser A, Alexander WS, Herold MJ.

Cell Death Differ. 2019 Oct 7. doi: 10.1038/s41418-019-0430-6. [Epub ahead of print]

PMID:
31591473
2.

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

Piawah S, Hyland C, Umetsu SE, Esserman LJ, Rugo HS, Chien AJ.

NPJ Breast Cancer. 2019 Jun 14;5:17. doi: 10.1038/s41523-019-0112-z. eCollection 2019.

3.

Benzoazepine-Fused Isoindolines via Intramolecular (3 + 2)-Cycloadditions of Azomethine Ylides with Dinitroarenes.

Wales SM, Rivinoja DJ, Gardiner MG, Bird MJ, Meyer AG, Ryan JH, Hyland CJT.

Org Lett. 2019 Jun 21;21(12):4703-4708. doi: 10.1021/acs.orglett.9b01580. Epub 2019 Jun 12.

PMID:
31188010
4.

Genetic Variants Within the Erythroid Transcription Factor, KLF1, and Reduction of the Expression of Lutheran and Other Blood Group Antigens: Review of the In(Lu) Phenotype.

Fraser NS, Knauth CM, Moussa A, Dean MM, Hyland CA, Perkins AC, Flower RL, Schoeman EM.

Transfus Med Rev. 2019 Apr;33(2):111-117. doi: 10.1016/j.tmrv.2019.01.004. Epub 2019 Feb 7. Review.

PMID:
31023581
5.

Organic diet intervention significantly reduces urinary pesticide levels in U.S. children and adults.

Hyland C, Bradman A, Gerona R, Patton S, Zakharevich I, Gunier RB, Klein K.

Environ Res. 2019 Apr;171:568-575. doi: 10.1016/j.envres.2019.01.024. Epub 2019 Feb 12.

6.

Developments beyond blood group serology in the genomics era.

Hyland CA, Roulis EV, Schoeman EM.

Br J Haematol. 2019 Mar;184(6):897-911. doi: 10.1111/bjh.15747. Epub 2019 Feb 1. Review.

PMID:
30706459
7.

Novel dual-action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine-specific histone demethylase 1A inhibitor.

Engel M, Gee YS, Cross D, Maccarone A, Heng B, Hulme A, Smith G, Guillemin GJ, Stringer BW, Hyland CJT, Ooi L.

J Neurochem. 2019 May;149(4):535-550. doi: 10.1111/jnc.14655. Epub 2019 Feb 3.

8.

Modified expression of the KEL2 (k) blood group antigen attributed to p.Leu196Val amino acid change three residues from the K/k antigen polymorphism site: implications for donor screening.

Millard GM, Lopez GH, Turner EM, Lizarazu ME, Roots NM, Liew YW, Flower RL, Hyland CA.

Transfusion. 2019 Mar;59(3):1156-1158. doi: 10.1111/trf.15106. Epub 2018 Dec 26. No abstract available.

PMID:
30586164
9.

Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data.

Schoeman EM, Roulis EV, Perry MA, Flower RL, Hyland CA.

Transfusion. 2019 Feb;59(2):768-778. doi: 10.1111/trf.15047. Epub 2018 Dec 6.

PMID:
30520525
10.

Dual Gold-Catalyzed Cycloaromatization of Unconjugated (E)-Enediynes.

Zamani F, Babaahmadi R, Yates BF, Gardiner MG, Ariafard A, Pyne SG, Hyland CJT.

Angew Chem Int Ed Engl. 2019 Feb 11;58(7):2114-2119. doi: 10.1002/anie.201810794. Epub 2019 Jan 17.

PMID:
30451362
11.

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings.

Storry JR, Clausen FB, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Yanli J, Keller M, Lomas-Francis C, Nogues N, Olsson ML, Peyrard T, van der Schoot E, Tani Y, Thornton N, Wagner F, Weinstock C, Wendel S, Westhoff C, Yahalom V.

Vox Sang. 2019 Jan;114(1):95-102. doi: 10.1111/vox.12717. Epub 2018 Nov 12.

PMID:
30421425
12.

Fifty years of RhD immunoglobulin (anti-D) therapy in Australia: celebrating a public health success story.

Thyer J, Wong J, Thomson A, Bell B, Hyland C, Challis D.

Med J Aust. 2018 Oct 15;209(8):336-339. No abstract available.

PMID:
30309307
13.

Investigation of the variable In(Lu) phenotype caused by KLF1 variants.

Fraser NS, Knauth CM, Schoeman EM, Moussa A, Perkins AC, Walsh T, Millard GM, Dean MM, Hyland CA, Flower RL.

Transfusion. 2018 Oct;58(10):2414-2420. doi: 10.1111/trf.14926. Epub 2018 Sep 17.

PMID:
30222867
14.

Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).

Turley E, McGowan EC, Hyland CA, Schoeman EM, Flower RL, Skoll A, Delisle MF, Nelson T, Clarke G, Au N.

Transfusion. 2018 Oct;58(10):2260-2264. doi: 10.1111/trf.14944. Epub 2018 Sep 17.

PMID:
30222865
15.

Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review.

Roulis E, Hyland C, Flower R, Gassner C, Jung HH, Frey BM.

JAMA Neurol. 2018 Dec 1;75(12):1554-1562. doi: 10.1001/jamaneurol.2018.2166. Review.

16.

Genotyping analysis of MNS blood group GP(B-A-B) hybrid glycophorins in the Chinese Southern Han population using a high-resolution melting assay.

Wei L, Lopez GH, Zhang Y, Wen J, Wang Z, Fu Y, Hyland CA, Flower RL, Luo G, Ji Y.

Transfusion. 2018 Jul;58(7):1763-1771. doi: 10.1111/trf.14641. Epub 2018 Jun 13.

PMID:
29897102
17.

Whole-genome sequencing algorithm for blood-group typing.

Flower R, Roulis E, Hyland C.

Lancet Haematol. 2018 Jun;5(6):e233-e234. doi: 10.1016/S2352-3026(18)30064-4. Epub 2018 May 17. No abstract available.

PMID:
29780002
18.

Maternal residential pesticide use and risk of childhood leukemia in Costa Rica.

Hyland C, Gunier RB, Metayer C, Bates MN, Wesseling C, Mora AM.

Int J Cancer. 2018 Sep 15;143(6):1295-1304. doi: 10.1002/ijc.31522. Epub 2018 Apr 26.

19.

A proposed new low-frequency antigen in the Augustine blood group system associated with a severe case of hemolytic disease of the fetus and newborn.

Millard GM, McGowan EC, Wilson B, Martin JR, Spooner M, Morris S, Farley R, James S, Liew YW, Schoeman EM, Dean MM, Flower RL, Hyland CA, Powley T, Roxby D.

Transfusion. 2018 May;58(5):1320-1322. doi: 10.1111/trf.14562. Epub 2018 Mar 5. No abstract available.

PMID:
29504136
20.

Vox Sanguinis International Forum on application of fetal blood grouping: summary.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):198-201. doi: 10.1111/vox.12616. Epub 2017 Dec 28. No abstract available.

PMID:
29282745
21.

Vox Sanguinis International Forum on application of fetal blood grouping.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):e26-e35. doi: 10.1111/vox.12615. Epub 2017 Dec 28. No abstract available.

PMID:
29282741
22.

A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms.

Lopez GH, Turner RM, McGowan EC, Schoeman EM, Scott SA, O'Brien H, Millard GM, Roulis EV, Allen AJ, Liew YW, Flower RL, Hyland CA.

Transfusion. 2018 Mar;58(3):685-691. doi: 10.1111/trf.14439. Epub 2017 Dec 6.

PMID:
29214630
23.

Pd-Catalyzed Dearomative [3 + 2] Cycloaddition of 3-Nitroindoles with 2-Vinylcyclopropane-1,1-dicarboxylates.

Gee YS, Rivinoja DJ, Wales SM, Gardiner MG, Ryan JH, Hyland CJT.

J Org Chem. 2017 Dec 15;82(24):13517-13529. doi: 10.1021/acs.joc.7b02624. Epub 2017 Dec 4.

PMID:
29129063
24.

Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting.

Schoeman EM, Roulis EV, Liew YW, Martin JR, Powley T, Wilson B, Millard GM, McGowan EC, Lopez GH, O'Brien H, Condon JA, Flower RL, Hyland CA.

Transfusion. 2018 Feb;58(2):284-293. doi: 10.1111/trf.14393. Epub 2017 Nov 8.

PMID:
29119571
25.

Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.

Au AE, Lebois M, Sim SA, Cannon P, Corbin J, Gangatirkar P, Hyland CD, Moujalled D, Rutgersson A, Yassinson F, Kile BT, Mason KD, Ng AP, Alexander WS, Josefsson EC.

Sci Rep. 2017 Nov 2;7(1):14953. doi: 10.1038/s41598-017-15023-2.

26.

Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types.

Hyland CA, Millard GM, O'Brien H, Schoeman EM, Lopez GH, McGowan EC, Tremellen A, Puddephatt R, Gaerty K, Flower RL, Hyett JA, Gardener GJ.

Pathology. 2017 Dec;49(7):757-764. doi: 10.1016/j.pathol.2017.08.010. Epub 2017 Oct 31.

PMID:
29096879
27.

Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.

Gordon LG, Hyland CA, Hyett JA, O'Brien H, Millard G, Flower RL, Gardener GJ.

Prenat Diagn. 2017 Dec;37(12):1245-1253. doi: 10.1002/pd.5176.

PMID:
29096422
28.

The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice.

Brinkmann K, Grabow S, Hyland CD, Teh CE, Alexander WS, Herold MJ, Strasser A.

Cell Death Differ. 2017 Dec;24(12):2032-2043. doi: 10.1038/cdd.2017.125. Epub 2017 Aug 11.

29.

Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor.

Lopez GH, McGowan EC, Condon JA, Schoeman EM, Millard GM, O'Brien H, Roulis EV, Ochoa-Garay G, Liew YW, Flower RL, Hyland CA.

Transfusion. 2017 Sep;57(9):2281-2283. doi: 10.1111/trf.14250. Epub 2017 Jul 16. No abstract available.

PMID:
28714065
30.

The BH3-only proteins BIM and PUMA are not critical for the reticulocyte apoptosis caused by loss of the pro-survival protein BCL-XL.

Delbridge AR, Aubrey BJ, Hyland C, Bernardini JP, Di Rago L, Garnier JM, Lessene G, Strasser A, Alexander WS, Grabow S.

Cell Death Dis. 2017 Jul 6;8(7):e2914. doi: 10.1038/cddis.2017.304.

31.

Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.

Quantock KM, Lopez GH, Hyland CA, Liew YW, Flower RL, Niemann FJ, Joyce A.

Transfusion. 2017 Aug;57(8):1938-1943. doi: 10.1111/trf.14156. Epub 2017 Jun 21.

PMID:
28639307
32.

Oxazolidinones and 2,5-Dihydrofurans via Zinc-Catalyzed Regioselective Allenylation Reactions of l-α-Amino Aldehydes.

Zamani F, Pyne SG, Hyland CJT.

J Org Chem. 2017 Jul 7;82(13):6819-6830. doi: 10.1021/acs.joc.7b00969. Epub 2017 Jun 14.

PMID:
28557457
33.

Review of take-home pesticide exposure pathway in children living in agricultural areas.

Hyland C, Laribi O.

Environ Res. 2017 Jul;156:559-570. doi: 10.1016/j.envres.2017.04.017. Epub 2017 Apr 26. Review.

PMID:
28437652
34.

Evaluation of targeted exome sequencing for 28 protein-based blood group systems, including the homologous gene systems, for blood group genotyping.

Schoeman EM, Lopez GH, McGowan EC, Millard GM, O'Brien H, Roulis EV, Liew YW, Martin JR, McGrath KA, Powley T, Flower RL, Hyland CA.

Transfusion. 2017 Apr;57(4):1078-1088. doi: 10.1111/trf.14054. Epub 2017 Mar 24.

PMID:
28338218
35.

Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.

McGowan EC, Lopez GH, Knauth CM, Liew YW, Condon JA, Ramadi L, Parsons K, Turner EM, Flower RL, Hyland CA.

Vox Sang. 2017 Apr;112(3):279-287. doi: 10.1111/vox.12488. Epub 2017 Feb 20.

PMID:
28220510
36.

Genetic factors associated with iron storage in Australian blood donors.

Ji Y, Flower R, Hyland C, Saiepour N, Faddy H.

Blood Transfus. 2018 Feb;16(2):123-129. doi: 10.2450/2016.0138-16. Epub 2016 Dec 21.

37.

Mitigating the Risk of Transfusion-Transmitted Dengue in Australia.

Rooks K, Seed CR, Fryk JJ, Hyland CA, Harley RJ, Holmberg JA, Marks DC, Flower RL, Faddy HM.

J Blood Transfus. 2016;2016:3059848. Epub 2016 Nov 13.

38.

An alloantibody in a homozygous GYP*Mur individual defines JENU (MNS49), a new high-frequency antigen on glycophorin B.

Lopez GH, Wilson B, Liew YW, Kupatawintu P, Emthip M, Hyland CA, Flower RL.

Transfusion. 2017 Mar;57(3):716-717. doi: 10.1111/trf.13952. Epub 2016 Dec 4. No abstract available.

PMID:
27917500
39.

Visible light dye-photosensitised oxidation of pyrroles using a simple LED photoreactor.

Howard JK, Rihak KJ, Hyland CJ, Bissember AC, Smith JA.

Org Biomol Chem. 2016 Sep 21;14(37):8873-8880.

PMID:
27722413
40.

Genotyping confirms inheritance of the rare At(a-) type in a case of haemolytic disease of the newborn.

McBean R, Liew YW, Wilson B, Kupatawintu P, Emthip M, Hyland C, Flower R.

J Pathol Clin Res. 2015 Dec 11;2(1):53-5. doi: 10.1002/cjp2.33. eCollection 2016 Jan.

41.

International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Storry JR, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Keller M, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Peyrard T, van der Schoot CE, Tani Y, Thornton N, Wagner F, Wendel S, Westhoff C, Yahalom V.

ISBT Sci Ser. 2016 Aug;11(2):118-122. doi: 10.1111/voxs.12280. Epub 2016 Jun 27.

42.

Genotyping for Glycophorin GYP(B-A-B) Hybrid Genes Using a Single Nucleotide Polymorphism-Based Algorithm by Matrix-Assisted Laser Desorption/Ionisation, Time-of-Flight Mass Spectrometry.

Wei L, Lopez GH, Ji Y, Condon JA, Irwin DL, Luo G, Hyland CA, Flower RL.

Mol Biotechnol. 2016 Oct;58(10):665-671. doi: 10.1007/s12033-016-9966-6.

PMID:
27435823
43.

A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype.

Lopez GH, McGowan EC, McGrath KA, Abaca-Cleopas ME, Schoeman EM, Millard GM, O'Brien H, Liew YW, Flower RL, Hyland CA.

Transfusion. 2016 Sep;56(9):2322-30. doi: 10.1111/trf.13713. Epub 2016 Jul 8.

PMID:
27390888
44.

Correction: Oxidative ring-opening of ferrocenylcyclopropylamines to N-ferrocenylmethyl β-hydroxyamides.

Gee YS, Goertz NJ, Gardiner MG, Hyland CJ.

Org Biomol Chem. 2016 May 4;14(18):4321.

PMID:
27098153
45.

Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.

Boland JM, Froemming AT, Wampfler JA, Maldonado F, Peikert T, Hyland C, de Andrade M, Aubry MC, Yang P, Yi ES.

Hum Pathol. 2016 May;51:41-50. doi: 10.1016/j.humpath.2015.12.010. Epub 2015 Dec 30.

PMID:
27067781
46.

Kv3.3 Channels Bind Hax-1 and Arp2/3 to Assemble a Stable Local Actin Network that Regulates Channel Gating.

Zhang Y, Zhang XF, Fleming MR, Amiri A, El-Hassar L, Surguchev AA, Hyland C, Jenkins DP, Desai R, Brown MR, Gazula VR, Waters MF, Large CH, Horvath TL, Navaratnam D, Vaccarino FM, Forscher P, Kaczmarek LK.

Cell. 2016 Apr 7;165(2):434-448. doi: 10.1016/j.cell.2016.02.009. Epub 2016 Mar 17.

47.

Dynamics of Mouth Opening in Hydra.

Carter JA, Hyland C, Steele RE, Collins EM.

Biophys J. 2016 Mar 8;110(5):1191-201. doi: 10.1016/j.bpj.2016.01.008.

48.

Optical measurement of the temporal delay between two ultra-short and focussed laser pluses.

Corvan DJ, Dzelzainis T, Hyland C, Nersisyan G, Yeung M, Zepf M, Sarri G.

Opt Express. 2016 Feb 8;24(3):3127-36. doi: 10.1364/OE.24.003127.

PMID:
26906877
49.

Oxidative ring-opening of ferrocenylcyclopropylamines to N-ferrocenylmethyl β-hydroxyamides.

Gee YS, Goertz NJ, Gardiner MG, Hyland CJ.

Org Biomol Chem. 2016 Feb 28;14(8):2498-503. doi: 10.1039/c5ob02577j.

PMID:
26814982
50.

GYP*Kip, a novel GYP(B-A-B) hybrid allele, encoding the MNS48 (KIPP) antigen.

Lopez GH, Wei L, Ji Y, Condon JA, Luo G, Hyland CA, Flower RL.

Transfusion. 2016 Feb;56(2):539-41. doi: 10.1111/trf.13450. Epub 2015 Dec 31. No abstract available.

PMID:
26718482

Supplemental Content

Loading ...
Support Center